Solja Niemelä
 Professor (Addiction Medicine)

    • Professor
    Psychiatry (Department of Clinical Medicine)


solnie@utu.fi

+358 40 528 1725

Kiinamyllynkatu 13

Turku

C5010


https://orcid.org/0000-0003-1130-9161

ResearchGate Profile





Addiction Medicine; Addiction Psychiatry; Psychosis and substance use; Dual Diagnosis; Substance-induced Psychosis; Prescription Medicine Misuse; Epidemiology


PRESENT POSITION

Professor (Addiction Medicine), Department of Psychiatry, University of Turku, 1.3.2023 -

Senior Physician, Addiction Psychiatry Unit, Turku University Hospital, Finland, 1.8.2018 -


EDUCATION AND TRAINING                                                                                                             

Licentiate of Medicine (MD), University of  Oulu, 1996

Specialist in Psychiatry, University of Turku, 2003

Special competence in Addiction Medicine, Finnish Medical Association, 2005

Doctor of Medical Sciences (PhD), University of Turku, 2008

Adjunct Professor (Psychiatry), University of Turku, 2011

Special competence in Medical Education, Finnish Medical Association, 2012

                                                                                       




My research group Turku Psychosis and Substance Use (TuPSU) focuses on epidemiology of substance use and psychosis. 

We aim to utilize national and regional register-based datasets, which enable to study substance-induced psychosis and co-occuring substance use among persons with psychotic disorders with minimal attrition, in these otherwise difficult-to-reach populations.  

The ongoing reserarch projects include e.g.: 

  • Substance-induced psychosis in Swedish national registeries (SIP-project). In collaboration with senior reseacher Heidi Taipale from the Karolinska Instute, Stockholm. Sweden
  • Substance use in the Turku University Hospital Datalake. Extensive patient record -based dataset with over 34,000 persons with substance-use-related admission at the Turku University Hospital. 
  • Substance use and dual diagnosis in the Finnish SUPER study including 10, 470 patients with psychotic disorders. In collaboration with Molecular Medicine Finland (FIMM), University of Helsinki and the Finnish Institute for Health and Welfare (THL). 
  • Health Survey of Finnish Prisoners (WATTU IV). In collaboration with National Health Instutute (THL). 






  
Go to first page
  
Go to previous page
  
1 of 6
  
Go to next page
  
Go to last page
  


Last updated on 2024-18-11 at 01:16